Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The role of protein corona on nanodrugs for organ-targeting and its prospects of application
S Wang, J Zhang, H Zhou, YC Lu, X **, L Luo… - Journal of Controlled …, 2023 - Elsevier
Nowadays, nanodrugs become a hotspot in the high-end medical field. They have the ability
to deliver drugs to reach their destination more effectively due to their unique properties and …
to deliver drugs to reach their destination more effectively due to their unique properties and …
[HTML][HTML] Translational challenges and prospective solutions in the implementation of biomimetic delivery systems
Biomimetic delivery systems (BDSs), inspired by the intricate designs of biological systems,
have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled …
have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled …
Real-time optical tracking of protein corona formation on single nanoparticles in serum
The formation of a protein corona, where proteins spontaneously adhere to the surface of
nanomaterials in biological environments, leads to changes in their physicochemical …
nanomaterials in biological environments, leads to changes in their physicochemical …
[HTML][HTML] Polymeric nanoparticles and nanogels: how do they interact with proteins?
Polymeric nanomaterials, nanogels, and solid nanoparticles can be fabricated using single
or double emulsion methods. These materials hold great promise for various biomedical …
or double emulsion methods. These materials hold great promise for various biomedical …
[HTML][HTML] Accelerating therapeutic protein design with computational approaches toward the clinical stage
Therapeutic protein, represented by antibodies, is of increasing interest in human medicine.
However, clinical translation of therapeutic protein is still largely hindered by different …
However, clinical translation of therapeutic protein is still largely hindered by different …
[HTML][HTML] Erythrocyte− cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer
S Rezaei, RF de Araújo Júnior, ILG da Silva… - Biomaterials …, 2023 - Elsevier
Cell-membrane-coated biomimetic nanoparticles (NPs) have attracted great attention due to
their prolonged circulation time, immune escape mechanisms and homotypic targeting …
their prolonged circulation time, immune escape mechanisms and homotypic targeting …
Protein Aggregation on Metal Oxides Governs Catalytic Activity and Cellular Uptake
Engineering of catalytically active inorganic nanomaterials holds promising prospects for
biomedicine. Catalytically active metal oxides show applications in enhancing wound …
biomedicine. Catalytically active metal oxides show applications in enhancing wound …
Optimal delivery strategies for nanoparticle-mediated mRNA delivery
Messenger RNA (mRNA) has emerged as a new and efficient agent for the treatment of
various diseases. The success of lipid nanoparticle-mRNA against the novel coronavirus …
various diseases. The success of lipid nanoparticle-mRNA against the novel coronavirus …
Homologous-adhering/targeting cell membrane-and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy
C Liu, J Gao, Y Cheng, S Zhang… - Regenerative …, 2024 - academic.oup.com
Low tumor enrichment remains a serious and urgent problem for drug delivery in cancer
therapy. Accurate targeting to tumor site is still a critical aim in cancer therapy. Though there …
therapy. Accurate targeting to tumor site is still a critical aim in cancer therapy. Though there …
Engineering oncolytic adenoviruses with VSVG‐decorated tumor cell membranes for synergistically enhanced antitumor therapy
LL Huang, W Wang, Z Wang, H Zhang… - Advanced Functional …, 2023 - Wiley Online Library
Oncolytic viruses hold great promise for cancer treatment but their practical applications are
seriously impaired by a series of limitations. Herein, an engineered oncolytic adenovirus …
seriously impaired by a series of limitations. Herein, an engineered oncolytic adenovirus …